All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0922-ZP991 | Anti-SLAMF7 (7A8D5) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 7A8D5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1019 | Anti-SLAMF7 (lotuzumab) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | lotuzumab | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1032 | Anti-SLAMF7 (huLuc63) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | huLuc63 | Humanized | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1301 | Anti-SLAMF7 (7A8D5) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 7A8D5 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1329 | Anti-SLAMF7 (lotuzumab) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | lotuzumab | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0922-ZP1342 | Anti-SLAMF7 (huLuc63) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | huLuc63 | Humanized | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
XS-0123-ZP47 | Anti-SLAMF7 (PDL241) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | PDL241 | Humanized | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP655 | Anti-SLAMF7 (7A8D5) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | 7A8D5 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP695 | Anti-SLAMF7 (lotuzumab) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | lotuzumab | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP714 | Anti-SLAMF7 (huLuc63) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | huLuc63 | Humanized | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0123-ZP715 | Anti-SLAMF7 (Luc90) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | Luc90 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
XS-0323-ZP47 | Anti-SLAMF7 (PDL241 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | PDL241 | Humanized | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP48 | Anti-SLAMF7 (Elotuzumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Elotuzumab | Humanized | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP270 | Anti-SLAMF7 (Luc63 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Luc63 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP271 | Anti-SLAMF7 (Ilofuzumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Ilofuzumab | Humanized | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP655 | Anti-SLAMF7 (7A8D5 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | 7A8D5 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP695 | Anti-SLAMF7 (lotuzumab scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | lotuzumab | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP714 | Anti-SLAMF7 (huLuc63 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | huLuc63 | Humanized | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0323-ZP715 | Anti-SLAMF7 (Luc90 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | Luc90 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
XS-0923-LX35 | Anti-hSLAMF7 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-4 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION